Better Outcomes from Autologous Transplants than Rituxan in Follicular Lymphoma

Autologous stem cell transplantation is linked to better survival outcomes in patients with follicular non-Hodgkin's lymphoma than any regimens featuring the monoclonal antibody Rituxan, according to findings from a multicenter study conducted chiefly by researchers from the British Columbia Cancer Agency.

Investigators sought to determine which transplant type (autologous or allogeneic) was best for patients diagnosed with transformed follicular non-Hodgkin's lymphoma, as well as whether either transplant type improved outcomes compared to Rituxan-based chemotherapy regimens.

In the study, the primary endpoint was Overall Survival (OS). There were three cohorts:

  1. Patients receiving an autologous stem cell transplantation (97 patients)
  2. Patients receiving an allogeneic stem cell transplantation (22 patients)
  3. Patients treated with rituximab regimens (53 patients)

The five-year overall survival rate, respectively, was found to be:

  1. 65 percent
  2. 46 percent
  3. 61 percent

The five-year progression-free survival rates were:

  1. 55 percent
  2. 46 percent
  3. 40 percent

Not surprisingly since the latter involves a host of additional potential problems, the five-year transplantation-related mortality rate was just five percent in the autologous cohort and 23 percent in the allogeneic group.

The team's findings have been published in the Journal of Clinical Oncology.

Source: JCO

More Articles

More Articles

Mantle cell lymphoma (MCL) is a rare type of B-Cell lymphoma. It presents itself in the mantle zone of lymph nodes...

Large Cell Lymphoma (LCL) is typically an aggressive (fast growing) cancer of either the B cell or T cell type. They are one of the most common...

Indolent Lymphoma, or Indolent Non-Hodgkin’s Lymphomas (NHLs), are slow growing, low-grade cancers (as opposed to ...

A lymphoma prognosis varies greatly depending on the type of lymphoma. There are more than 35 types of lymphoma, including 5 types of...

Lymphomas are classified based on the type of cells involved. Non-Hodgkin’s lymphomas are marked by mutations of...

Hodgkin's Lymphoma (Disease) has a colorful history: It was not the first cancer discovered but it was one of the first in which treatments were...

There are two types of cancer: benign and malignant. Benign cancers are the kind that don't spread and don't threaten one's life. Malignant...

Cancer bracelets are undeniably popular, and if purchased through reliable sources such as major charities, they help contribute to the fight...

Hodgkin's Disease—also referred to as Hodgkin's Lymphoma, these are the exact same diseases, just...

Lymphoma is a cancer of the b- and t-cell lymphocytes, part of the immune system. They account for the most frequent head and neck malignancies....

Lymphoma is a cancer of the lymphatic system, causing B-cell or...

Lymphoma is a cancer affecting the white blood cells (lymphocytes) of the body's immune system. The cells begin to grow abnormally and much faster...

As a kind of cancer, lymphoma attacks the lymphocytes and lymph nodes that are part of the immune system. Head and neck lymphoma results when...

Some cancers have clear environmental causes. Oral cancer is strongly tied to the use of chewing tobacco, and lung cancer is well-known to be much...

The Follicular Lymphoma International Prognostic Index, or FLIPI, is a standardized guide to help oncological diagnosticians accurately calculate...